|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.60 EUR | -0.37% |
|
+5.55% | +55.68% |
| Jul. 09 | Orion raises outlook for 2025 | RE |
| Jul. 09 | Orion Upgrades FY25 Net Sales, Operating Profit Outlook | MT |
| Capitalization | 9.36B 10.94B 8.71B 8.11B 14.97B 938B 16.62B 105B 39.84B 439B 41.02B 40.17B 1,612B | P/E ratio 2025 * |
25.6x | P/E ratio 2026 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 9.4B 10.99B 8.75B 8.15B 15.04B 943B 16.7B 105B 40.03B 441B 41.21B 40.36B 1,620B | EV / Sales 2025 * |
5.6x | EV / Sales 2026 * | 4.66x |
| Free-Float |
89.32% | Yield 2025 * |
2.58% | Yield 2026 * | 2.78% |
More valuation ratios
* Estimated data
More news
Last Transcript: Orion Oyj
More recommendations
More press releases
More news
| 1 day | -0.37% | ||
| 1 week | +7.25% | ||
| Current month | +4.31% | ||
| 1 month | +5.71% | ||
| 3 months | +37.32% | ||
| 6 months | +47.57% | ||
| Current year | +55.68% |
| 1 week | 62.7 |  | 67.7 |
| 1 month | 61.7 | | 67.7 |
| Current year | 42.8 | | 67.7 |
| 1 year | 39.39 | | 67.7 |
| 3 years | 31.86 | | 67.7 |
| 5 years | 31.86 | | 67.7 |
| 10 years | 22.57 | | 67.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2022-10-31 | |
René Lindell
DFI | Director of Finance/CFO | 49 | 2024-04-30 |
| Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Eija Ronkainen
BRD | Director/Board Member | 59 | 2016-03-21 |
| Director/Board Member | 62 | 2017-03-21 | |
Hilpi Rautelin
BRD | Director/Board Member | 64 | 2017-03-21 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 2.96% | 806 M€ | +8.43% | - | |
| 2.87% | 478 M€ | +15.60% | - | |
| 0.52% | 0 M€ | -.--% | - | |
| 0.35% | 1,022 M€ | +19.74% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +7.25% | +63.28% | +51.33% | 10.98B | ||
| +0.30% | +1.58% | -15.62% | +139.96% | 710B | ||
| -0.50% | +0.57% | +5.00% | -11.99% | 379B | ||
| -1.31% | +1.67% | +14.46% | +25.91% | 344B | ||
| -3.64% | +0.24% | -55.03% | +9.87% | 317B | ||
| -2.36% | -0.31% | +3.13% | -20.22% | 265B | ||
| -3.00% | -0.59% | -2.11% | +16.28% | 244B | ||
| -1.66% | +2.41% | -13.48% | -5.38% | 223B | ||
| -0.79% | +3.00% | -34.52% | -10.15% | 211B | ||
| -1.70% | -1.00% | -8.21% | +18.83% | 162B | ||
| Average | -1.31% | +2.01% | -4.31% | +21.44% | 286.56B | |
| Weighted average by Cap. | -1.23% | +1.13% | -11.25% | +36.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.68B 1.96B 1.56B 1.45B 2.68B 168B 2.98B 18.76B 7.14B 78.8B 7.36B 7.2B 289B | 1.97B 2.31B 1.84B 1.71B 3.16B 198B 3.51B 22.08B 8.41B 92.74B 8.66B 8.48B 340B |
| Net income | 366M 428M 341M 318M 586M 36.76B 651M 4.1B 1.56B 17.21B 1.61B 1.57B 63.15B | 534M 624M 497M 463M 854M 53.54B 948M 5.97B 2.27B 25.07B 2.34B 2.29B 92B |
| Net Debt | 44.11M 51.55M 41.06M 38.22M 70.57M 4.42B 78.34M 493M 188M 2.07B 193M 189M 7.6B | -145M -169M -135M -125M -232M -14.51B -257M -1.62B -616M -6.8B -634M -621M -24.94B |
More financial data
* Estimated data
Employees
3,943
Sector
Pharmaceuticals
Calendar
Jul. 18
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 66.60 € | -0.37% | 133,967 |
| 25-07-10 | 66.85 € | +1.83% | 221,243 |
| 25-07-09 | 65.65 € | 0.00% | 393,891 |
| 25-07-08 | 65.65 € | +3.55% | 307,083 |
| 25-07-07 | 63.40 € | +0.48% | 149,917 |
Delayed Quote Nasdaq Helsinki, July 11, 2025 at 12:00 pm EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
66.60EUR
Average target price
58.50EUR
Spread / Average Target
-12.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ORNBV Stock
Select your edition
All financial news and data tailored to specific country editions
